Business Description
Outset Medical Inc
NAICS : 339112
SIC : 3845
ISIN : US6901452069
Share Class Description:
OM: Ordinary SharesTotal Employee Number:
310Description
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.41 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.08 | |||||
Debt-to-EBITDA | -1.83 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -6.13 | |||||
Beneish M-Score | -3.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39.8 | |||||
3-Year EBITDA Growth Rate | 55.9 | |||||
3-Year EPS without NRI Growth Rate | 53.3 | |||||
3-Year FCF Growth Rate | 59.9 | |||||
3-Year Book Growth Rate | -54.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 25 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.76 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.11 | |||||
9-Day RSI | 22.7 | |||||
14-Day RSI | 30.59 | |||||
3-1 Month Momentum % | 13.43 | |||||
6-1 Month Momentum % | 54.09 | |||||
12-1 Month Momentum % | -64.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.19 | |||||
Quick Ratio | 4.11 | |||||
Cash Ratio | 3.35 | |||||
Days Inventory | 261.88 | |||||
Days Sales Outstanding | 93.4 | |||||
Days Payable | 10.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -77.8 | |||||
Shareholder Yield % | 74.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.76 | |||||
Operating Margin % | -55.59 | |||||
Net Margin % | -63.06 | |||||
EBITDA Margin % | -48.34 | |||||
FCF Margin % | -33 | |||||
OCF Margin % | -32.53 | |||||
ROE % | -58.76 | |||||
ROA % | -28.09 | |||||
ROIC % | -74.79 | |||||
3-Year ROIIC % | -856.38 | |||||
ROC (Joel Greenblatt) % | -105.35 | |||||
ROCE % | -26.41 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.55 | |||||
PB Ratio | 0.67 | |||||
Price-to-Tangible-Book | 0.67 | |||||
EV-to-EBIT | -0.36 | |||||
EV-to-EBITDA | -0.38 | |||||
EV-to-Revenue | 0.18 | |||||
EV-to-Forward-Revenue | 0.16 | |||||
EV-to-FCF | -0.55 | |||||
Price-to-GF-Value | 0.84 | |||||
| Price-to-Net-Current-Asset-Value | 0.79 | |||||
| Price-to-Net-Cash | 56.92 | |||||
Earnings Yield (Greenblatt) % | -277.78 | |||||
FCF Yield % | -60.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Outset Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 117.803 | ||
| EPS (TTM) ($) | -4.09 | ||
| Beta | 3.5119 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 88.9 | ||
| 14-Day RSI | 30.59 | ||
| 14-Day ATR ($) | 0.273312 | ||
| 20-Day SMA ($) | 4.1055 | ||
| 12-1 Month Momentum % | -64.52 | ||
| 52-Week Range ($) | 3 - 16.16 | ||
| Shares Outstanding (Mil) | 18.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Outset Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Outset Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-12 | In 156 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-11 16:30 | In 156 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-11 | In 155 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-10 16:30 | In 63 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 62 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 16:30 | 5.12 (-2.10%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 5.12 (-2.10%) | ||
| General meeting for 2026 | 2026-06-04 13:30 | 4.60 (-6.88%) | ||
| RBC Capital Markets Global Health Care conference | 2026-05-19 10:30 | 3.72 (+3.33%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 4.51 (-6.63%) |
Show
Entries
Outset Medical Inc Frequently Asked Questions
What is Outset Medical Inc(OM)'s stock price today?
The current price of OM is $3.42. The 52 week high of OM is $16.16 and 52 week low is $3.00.
When is next earnings date of Outset Medical Inc(OM)?
The next earnings date of Outset Medical Inc(OM) is 2026-11-10 Est..
Does Outset Medical Inc(OM) pay dividends? If so, how much?
Outset Medical Inc(OM) does not pay dividend.
Guru Commentaries on NAS:OM
Minot Light Capital Partners
Neutral
2026 Q2
What the manager wrote
In previous letters we have spoken about both Outset Medical (OM) and MaxCyte (MXCT), both of which were companies where we were able to purchase shares below net cash on the balance sheet, despite core businesses with several attractive characteristics. We will admit, these can be some of the most frustrating stocks to own in the near-term, but over time, as we have been able to lower our average cost on both names, they have made us money and eventually contributed nicely to partnership returns.
Minot Light Capital Partners
Bullish
2026 Q1
What the manager wrote
Outset Medical (OM) was our biggest contributor this quarter and a top detractor last quarter. The stock fell to prices well below net cash on the balance sheet following a weak earnings report, despite a reasonably strong core business that is characterized by meaningful recurring revenues. This allowed us to buy more stock post-decline and we benefitted from the current rebound off depressed levels this quarter.
Press Release
Articles on Outset Medical Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers